Here, we performed a multimodal, dual-tracer imaging study in a syngeneic mouse model of glioma applying 18F-FET and 18F-DPA-714 PET using a CSF-1R inhibitor to investigate the interplay between glioma progression and related immune cell dynamics. The gene discussed is CSF1R; the disease is central nervous system cancer.